Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Seattle Genetics Inc (NASDAQ:SGEN)

58.79
Delayed Data
As of Jan 20
 -0.48 / -0.81%
Today’s Change
26.02
Today|||52-Week Range
75.36
+11.41%
Year-to-Date
5 Expensive Drugs That Could End Up in Trump's Crosshairs
Jan 18 / MotleyFool.com - Paid Partner Content
After ARIAD's Acquisition, These 3 Cancer Drug Stocks Could Be Next
Jan 10 / MotleyFool.com - Paid Partner Content